A Controlled Study of Solriamfetol for Attention Deficit Hyperactivity Disorder (ADHD) in Adults
Clinical trial NCT04839562 · COMPLETED
Trial details
- NCT number
- NCT04839562
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-06
- Primary completion
- 2023-01-27
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.